Keyphrases
Phase II Trial
100%
Cisplatin
100%
Primary Brain Tumor
100%
Intracarotid
100%
Stable Disease
80%
In(III)
40%
Neurotoxicity
40%
Primary Tumor
40%
Prior Chemotherapy
40%
Retinal Toxicity
40%
Brain Metastases
20%
Computed Tomography
20%
Hemiparesis
20%
Seizure
20%
Lethargy
20%
Leukoencephalopathy
20%
Median Time
20%
Tumor Regression
20%
Blindness
20%
Cranial Irradiation
20%
Blurring of Vision
20%
Time to Tumor Progression
20%
Expressive Aphasia
20%
Recurrent Glioma
20%
Medicine and Dentistry
Cisplatin
100%
Phase II Trials
100%
Brain Cancer
100%
Carmustine
100%
Diseases
80%
Primary Tumor
40%
Patient History of Chemotherapy
40%
Malignant Neoplasm
20%
Tumor Progression
20%
Infusion
20%
Hemiparesis
20%
Epileptic Seizure
20%
Leukoencephalopathy
20%
Brain Metastasis
20%
Ganglioglioma
20%
Transient Ischemic Attack
20%
Tumor Regression
20%
Skull Irradiation
20%
Expressive Aphasia
20%
X-Ray Computed Tomography
20%
Neuroscience
Cisplatin
100%
Intracranial Tumor
100%
Hemiparesis
20%
Leukoencephalopathy
20%
Expressive Aphasia
20%
X-Ray Computed Tomography
20%